VACE Advisory · Capability 02

Access

From Regulatory Strategy to Market Access

One coordinated pathway — from regulatory strategy and product registration through pricing, reimbursement, payer engagement and institutional access

The Access pathway

From regulatory authorization to market and patient access

VACE regulatory-to-access continuum: regulatory strategy, registration, pricing and reimbursement, payer and institutional access, and market access.
VACE regulatory-to-access continuum: regulatory strategy, registration, pricing and reimbursement, payer and institutional access, and market access.
Capability depth

Two connected components. One Access capability

Regulatory Affairs & Registration

Market Access

Market authorization

Market and patient access

Strategy & Pathways
Regulatory Strategy • Registration Pathway Assessment • Regulatory Intelligence

Strategy & Pricing
Market Access Strategy • Pricing & Reimbursement • HTA / Access Pathway Navigation

Registration & Submissions
Product Registration • Dossier Strategy & Submission Support • Health Authority Engagement • Regional Regulatory Coordination

Payers & Stakeholders
Payer Strategy & Engagement • Access Stakeholder Mapping

Compliance & Lifecycle
Regulatory Compliance • Lifecycle Management • Regulatory Change Management

Institutional & Public Sector
Institutional Access • Formulary Access • Tender & Procurement Strategy • Public-Sector Access

Where relevant to the engagement: Pharmacovigilance & Safety Compliance.

What we address

Where access breaks down

Complex pathways & registration delays

Pricing, reimbursement & payer barriers

Disconnected planning

Misalignment between regulatory, access and commercial planning

Unclear regulatory pathways, submission challenges and fragmented requirements across markets

Fragmented payer environments and limited formulary and institutional access

Outcome

A clearer, coordinated pathway from regulatory authorization to market and patient access